Characterization of Fetal Lung With Quantitative Ultrasound
Launched by UNIVERSITY OF WISCONSIN, MADISON · Dec 3, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is investigating a new way to check a baby’s lungs using a special ultrasound technique called backscatter quantitative ultrasound (bQUS). The goal is to see if this method can provide valuable information about the lungs when mothers are around 36 weeks pregnant. The study will involve 12 pregnant women who will participate in a single 30-minute ultrasound between 32 and 36 weeks of pregnancy.
To join this study, women must be between 18 and 45 years old, be expecting one baby (not twins or more), have a live fetus, and be scheduled for a routine ultrasound to check the baby’s growth. They should not be in labor and must meet certain health criteria. During the ultrasound, participants can expect to lie comfortably while the technician uses the ultrasound equipment to evaluate the baby’s lungs. This research could help improve how doctors monitor fetal lung health in the future.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Pregnant females ages 18 to 45 years old with singleton pregnancy, live fetus, gestational age between 32.1 and 36.7 weeks, not in labor, scheduled for routine ultrasound growth evaluation.
- • Gestational age determined by the date of the last menses, and confirmed by measurement of the crown-rump-length on transabdominal ultrasound.
- Exclusion Criteria:
- • Subjects unable to consent.
- • Active Labor
- • Fetal malformations of the lungs
- • Prescription of corticosteroids prior to ultrasound evaluation
- • Pre-gestation or gestational diabetes mellitus
- • Low English proficiency, needing an interpreter
About University Of Wisconsin, Madison
The University of Wisconsin-Madison is a leading research institution renowned for its commitment to advancing healthcare through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, the university leverages its extensive resources, including cutting-edge facilities and a diverse pool of expert researchers, to conduct rigorous studies that address critical health challenges. The institution's focus on translating research findings into practical applications fosters the development of new treatments and interventions, ultimately contributing to improved patient outcomes and public health initiatives. As a sponsor of clinical trials, the University of Wisconsin-Madison is dedicated to upholding the highest ethical standards and ensuring participant safety throughout the research process.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Madison, Wisconsin, United States
Patients applied
Trial Officials
J. Igor Iruretagoyena, MD, MS
Principal Investigator
UW School of Medicine and Public Health
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported